Skip to main content
. Author manuscript; available in PMC: 2021 Sep 23.
Published in final edited form as: Cancer. 2020 Sep 23;127(1):82–92. doi: 10.1002/cncr.33208

Table 3.

Univariate outcome in African American and Caucasians with or without t(11;14)

AA w t(11;14)
(N = 117)
AA w/o t(11;14)
(N = 968)
Whites w t(11;14)
(N = 266)
Whites w/o t(11;14)
(N = 2,187)
Outcomes N Prob
(95% CI)
N Prob
(95% CI)
N Prob
(95% CI)
N Prob
(95% CI)
p-value
TRM 115 959 259 2164 0.68
100-day 1 (0–3)% 1 (0–1)% 1 (0–3)% 1 (0–1)% 0.77
1-year 2 (0–5)% 1 (1–2)% 3 (1–5)% 2 (1–2)% 0.66
2-year 2 (0–5)% 2 (1–3)% 3 (1–6)% 2 (2–3)% 0.79
PFS 115 959 259 2164 0.06
1-year 84 (76–90)% 81 (78–83)% 76 (70–81)% 79 (78–81)% 0.20
2-year 65 (54–74)% 65 (61–68)% 54 (47–60)% 61 (59–63)% 0.02
OS 117 968 266 2187 0.41
1-year 95 (90–98)% 95 (94–97)% 93 (90–96)% 95 (94–96)% 0.69
2-year 91 (85–96)% 89 (86–91)% 86 (81–90)% 87 (86–89)% 0.35

AA; Africans Americans, N; number, Prob; probability, w; with, w/o without, TRM; transplant related mortality, PFS; progression free survival, OS; overall survival, N; number evaluated